1. Hansson GK, Libby P, Tabas I (2015) Infammation and plaque vulnerability. J Intern Med 278(5):483–493
2. Owens GK, Kumar MS, Wamhof BR (2004) Molecular regulation of vascular smooth muscle cell diferentiation in development and disease. Physiol Rev 84(3):767–801
3. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362(6423):801–809
4. Feil S, Fehrenbacher B, Lukowski R, Essmann F, Schulze-Osthof K, Schaller M, Feil R (2014) Transdiferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis. Circ Res 115(7):662–667
5. Shankman LS, Gomez D, Cherepanova OA, Salmon M, Alencar GF, Haskins RM, Swiatlowska P, Newman AA, Greene ES, Straub AC, Isakson B, Randolph GJ, Owens GK (2015) KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med 21(6):628–637
6. Allahverdian S, Chehroudi AC, McManus BM, Abraham T, Francis GA (2014) Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation 129(15):1551–1559
7. Vengrenyuk Y, Nishi H, Long X, Ouimet M, Savji N, Martinez FO, Cassella CP, Moore KJ, Ramsey SA, Miano JM, Fisher EA (2015) Cholesterol loading reprograms the microRNA143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype. Arterioscler Thromb Vasc Biol 35(3):535–546
8. Schrijvers DM, De Meyer GR, Kockx MM, Herman AG, Martinet W (2005) Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler Thromb Vasc Biol 25(6):1256–1261
9. Moore KJ, Freeman MW (2006) Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 26(8):1702–1711
10. Naito M, Suzuki H, Mori T, Matsumoto A, Kodama T, Takahashi K (1992) Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am J Pathol 141(3):591–599
11. Li W, Febbraio M, Reddy SP, Yu DY, Yamamoto M, Silverstein RL (2010) CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs. J Clin Invest 120(11):3996–4006
12. Aoyama T, Chen M, Fujiwara H, Masaki T, Sawamura T (2000) LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells. FEBS Lett 467(2–3):217–220
13. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T (1997) An endothelial receptor for oxidized low-density lipoprotein. Nature 386(6620):73–77
14. Draude G, Hrboticky N, Lorenz RL (1999) The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its downregulation by lovastatin. Biochem Pharmacol 57(4):383–386
15. Li D, Mehta JL (2009) Intracellular signaling of LOX-1 in endothelial cell apoptosis. Circ Res 104(5):566–568
16. Tarabykina S, Grifths TR, Tulchinsky E, Mellon JK, Bronstein IB, Kriajevska M (2007) Metastasis-associated protein S100A4: spotlight on its role in cell migration. Curr Cancer Drug Targets 7(3):217–228
17. Chaabane C, Coen M, Bochaton-Piallat ML (2014) Smooth muscle cell phenotypic switch: implications for foam cell formation. Curr Opin Lipidol 25(5):374–379
18. Nagata M, Minami M, Yoshida K, Yang T, Yamamoto Y, Takayama N, Ikedo T, Hayashi K, Miyata T, Yokode M, Miyamoto S (2020) Calcium-binding protein S100A4 is upregulated in carotid atherosclerotic plaques and contributes to expansive remodeling. J Am Heart Assoc. https://doi.org/10.1161/JAHA.120.016128
19. Sack U, Walther W, Scudiero D, Selby M, Kobelt D, Lemm M, Fichtner I, Schlag PM, Shoemaker RH, Stein U (2011) Novel efect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer. J Natl Cancer Inst 103(13):1018–1036
20. Li Y, Li PK, Roberts MJ, Arend RC, Samant RS, Buchsbaum DJ (2014) Multi-targeted therapy of cancer by niclosamide: a new application for an old drug. Cancer Lett 349(1):8–14
21. Ye T, Xiong Y, Yan Y, Xia Y, Song X, Liu L, Li D, Wang N, Zhang L, Zhu Y, Zeng J, Wei Y, Yu L (2014) The anthelmintic drug niclosamide induces apoptosis, impairs metastasis and reduces immunosuppressive cells in breast cancer model. PLoS One. https:// doi.org/10.1371/journal.pone.0085887
22. Jin Y, Lu Z, Ding K, Li J, Du X, Chen C, Sun X, Wu Y, Zhou J, Pan J (2010) Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species. Cancer Res 70(6):2516–2527
23. Tao H, Zhang Y, Zeng X, Shulman GI, Jin S (2014) Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice. Nat Med 20(11):1263–1269
24. Nam D, Ni CW, Rezvan A, Suo J, Budzyn K, Llanos A, Harrison D, Giddens D, Jo H (2009) Partial carotid ligation is a model of acutely induced disturbed fow, leading to rapid endothelial dysfunction and atherosclerosis. Am J Physiol Heart Circ Physiol 297(4):H1535-1543
25. Ohayon J, Finet G, Gharib AM, Herzka DA, Tracqui P, Heroux J, Rioufol G, Kotys MS, Elagha A, Pettigrew RI (2008) Necrotic core thickness and positive arterial remodeling index: emergent biomechanical factors for evaluating the risk of plaque rupture. Am J Physiol Heart Circ Physiol 295(2):H717-727
26. Andres-Manzano MJ, Andres V, Dorado B (2015) Oil red O and hematoxylin and eosin staining for quantifcation of atherosclerosis burden in mouse aorta and aortic root. Methods Mol Biol 1339:85–99
27. Whittaker P, Kloner RA, Boughner DR, Pickering JG (1994) Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic Res Cardiol 89(5):397–410
28. Ivan E, Khatri JJ, Johnson C, Magid R, Godin D, Nandi S, Lessner S, Galis ZS (2002) Expansive arterial remodeling is associated with increased neointimal macrophage foam cell content: the murine model of macrophage-rich carotid artery lesions. Circulation 105(22):2686–2691
29. Varghese F, Bukhari AB, Malhotra R, De A (2014) IHC Profler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One. https://doi.org/10.1371/journal.pone.0096801
30. Stoll LL, Denning GM, Weintraub NL (2004) Potential role of endotoxin as a proinfammatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol 24(12):2227–2236
31. Nagase M, Abe J, Takahashi K, Ando J, Hirose S, Fujita T (1998) Genomic organization and regulation of expression of the lectinlike oxidized low-density lipoprotein receptor (LOX-1) gene. J Biol Chem 273(50):33702–33707
32. Shibata Y, Kume N, Arai H, Hayashida K, Inui-Hayashida A, Minami M, Mukai E, Toyohara M, Harauma A, Murayama T, Kita T, Hara S, Kamei K, Yokode M (2007) Mulberry leaf aqueous fractions inhibit TNF-alpha-induced nuclear factor kappaB (NF-kappaB) activation and lectin-like oxidized LDL receptor-1 (LOX-1) expression in vascular endothelial cells. Atherosclerosis 193(1):20–27
33. Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, Rigoni A, Pastorino AM, Lo Cascio V, Sawamura T (2000) Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 275(17):12633–12638
34. Xu S, Ogura S, Chen J, Little PJ, Moss J, Liu P (2013) LOX-1 in atherosclerosis: biological functions and pharmacological modifers. Cell Mol Life Sci 70(16):2859–2872
35. Chen W, Mook RA Jr, Premont RT, Wang J (2018) Niclosamide: beyond an antihelminthic drug. Cell Signal 41:89–96
36. Wieland A, Trageser D, Gogolok S, Reinartz R, Hofer H, Keller M, Leinhaas A, Schelle R, Normann S, Klaas L, Waha A, Koch P, Fimmers R, Pietsch T, Yachnis AT, Pincus DW, Steindler DA, Brustle O, Simon M, Glas M, Schefer B (2013) Anticancer efects of niclosamide in human glioblastoma. Clin Cancer Res 19(15):4124–4136
37. Xiao XL, Hu N, Zhang XZ, Jiang M, Chen C, Ma R, Ma ZG, Gao JL, Xuan XC, Sun ZJ, Dong DL (2018) Niclosamide inhibits vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in injured rat carotid arteries. Br J Pharmacol 175(10):1707–1718
38. Aoki C, Hattori Y, Tomizawa A, Jojima T, Kasai K (2010) Antiinfammatory role of cilostazol in vascular smooth muscle cells in vitro and in vivo. J Atheroscler Thromb 17(5):503–509
39. Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F, Satoh H, Inoue K, Kawase Y, Jishage K, Suzuki H, Takeya M, Schnackenberg L, Beger R, Hermonat PL, Thomas M, Sawamura T (2007) Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res 100(11):1634–1642
40. Stein S, Lohmann C, Schafer N, Hofmann J, Rohrer L, Besler C, Rothgiesser KM, Becher B, Hottiger MO, Boren J, McBurney MW, Landmesser U, Luscher TF, Matter CM (2010) SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. Eur Heart J 31(18):2301–2309
41. Xia X, Li Y, Su Q, Huang Z, Shen Y, Li W, Yu C (2015) Inhibitory efects of Mycoepoxydiene on macrophage foam cell formation and atherosclerosis in ApoE-defcient mice. Cell Biosci 5(1):23
42. Rayner KJ (2017) Cell death in the vessel wall: the good, the bad, the ugly. Arterioscler Thromb Vasc Biol 37(7):e75–e81
43. Chang X, Zhen X, Liu J, Ren X, Hu Z, Zhou Z, Zhu F, Ding K, Nie J (2017) The antihelmenthic phosphate niclosamide impedes renal fbrosis by inhibiting homeodomain-interacting protein kinase 2 expression. Kidney Int 92(3):612–624
44. Ghebes CA, van Lente J, Post JN, Saris DB, Fernandes H (2017) High-throughput screening assay identifes small molecules capable of modulating the BMP-2 and TGF-beta1 signaling pathway. SLAS Discov 22(1):40–50
45. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J (2001) Pravastatin treatment increases collagen content and decreases lipid content, infammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103(7):926–933
46. Rippe RA, Schrum LW, Stefanovic B, Solis-Herruzo JA, Brenner DA (1999) NF-kappaB inhibits expression of the alpha1(I) collagen gene. DNA Cell Biol 18(10):751–761
47. Roebuck KA, Vermes C, Carpenter LR, Fritz EA, Narayanan R, Glant TT (2001) Down-regulation of procollagen alpha1[I]] messenger RNA by titanium particles correlates with nuclear factor kappaB (NF-kappaB) activation and increased rel A and NF-kappaB1 binding to the collagen promoter. J Bone Miner Res 16(3):501–510
論文の公開元へ
